Applications of ribosome display to antibody drug discovery

Bibliography

• WI H, AN LL: Tailoring kinetics of antibodies using focused combinatorial libraries. Methods MoL Biol (2004) 207:213–233.
   Google Scholar
• ROHRBACH P, BRODERS O, TOLEIKIS L, DUBEL S: Therapeutic antibodies and antibody fusion proteins. Biotechnol Genet. Eng. Rev. (2003) 20(7):137–163.
   PubMedGoogle Scholar
• VAN DIJK MA, VAN DE WINKEL JG: Human antibodies as the next generation therapeutics. Curr. Opin. Chem. Biol. (2001) 5:368–374.
   PubMed Web of Science ®Google Scholar
• BREKKE OH, SANDLIE I: Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat. Rev. Drug Discov. (2003) 2(1):52–62.
   PubMed Web of Science ®Google Scholar
• MONZAVI-KARBASSI B, KIEBER-EMMONS T: Current concepts in cancer vaccine strategies. Biotechniques (2001) 30:170–189.
   PubMed Web of Science ®Google Scholar
• KOHLER G, MILSTEIN C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 256(5517):495–497.
   PubMed Web of Science ®Google Scholar
• COURTENAY-LUCK NS, EPENETOS AA, MOORE R et al.: Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res. (1986) 46:6489–6493.
   PubMed Web of Science ®Google Scholar
• LAMERS CH, GRATAMA JW, WARNAAR SO, STOTER G, BOLHIUS RL: Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T lymphocytes. Int. J. Cancer (1995) 60:450–457.
   PubMed Web of Science ®Google Scholar
• WINTER G, HARRIS WJ: Humanized antibodies. Immunol Today (1993) 14(6):243–246.
   PubMedGoogle Scholar
• ROGUSKA MA, PEDERSON JT, KEDDY CA et al.: Humanization of murine monoclonal antibodies through variable domain resurfacing. Proc. Nail Acad. Sci. USA (1994) 91(3):969–973.
   PubMed Web of Science ®Google Scholar
• PENDLEY C, SCHANTZ A, WAGNER C: Immunogenicity of therapeutic monoclonal antibodies. Curr. Opin. Mol Ther. (2003) 5:172–179.
   PubMedGoogle Scholar
• WINTER G, MILSTEIN C: Man-made antibodies. Nature (1991) 349(6307):293–299.
   PubMed Web of Science ®Google Scholar
• MCCAFFERTY J, GRIFFITHS AD, WINTER G, CHISWELL DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature (1990) 348 (6301): 552–554.
   PubMed Web of Science ®Google Scholar
• MARKS JD, HOOGENBOOM HR, BONNERT TP et al.: By-passing immunisation. Human antibodies from V-gene libraries displayed on phage. J. Mol Biol (1991) 222(3):581–597.
   Google Scholar
• GRIFFITHS AD, MALMQVIST M, MARKS JD et al.: Human anti-self antibodies with high specificity from phage display libraries. EMBO J. (1993) 12(2):725–734.
   PubMed Web of Science ®Google Scholar
• VAUGHAN TJ, WILLIAMS AJ, PRITCHARD K et al.: Human antibodies with sub-nanomolar affinities isolated from a large non-immunised phage display library. Nat. Biotechnol (1996) 14(3):309–314.
   PubMed Web of Science ®Google Scholar
• EDWARDS BM, BARASH SC, MAIN SH et al.: The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, blys. J. Mot Bid. (2003) 334:103–118.
   PubMed Web of Science ®Google Scholar
• GREEN LL, HARDY MC, MAYNARD-CURRIE CE et al.: Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Genet. (1994) 7:13–21.
   PubMed Web of Science ®Google Scholar
• MENDEZ MJ, GREEN LL, CORVALAN JR et al.: Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat. Genet. (1997) 15:146–156.
   PubMed Web of Science ®Google Scholar
• JESPERS LS, ROBERTS A, MAHLER SM, WINTER G, HOOGENBOOM HR: Guiding the selection of phage display antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology (N1) (1994) 12(9):899–903.
   Google Scholar
• SCHAFFITZEL C, ZAHND C, AMSTUTZ P, LUGINBUHL B, PLUCKTHUN A: In vitro selection and evolution of protein:ligand interactions by ribosome display. In: Protein-Protein Interactions. A Molecular Cloning Manual. Golemis E (Ed.), Cold Spring Harbor Laboratory Press, New York, USA (200 1) :535–567.
   Google Scholar
• ••Very good technical description of theribosome display process.
   Google Scholar
• HANES J, JERMUTUS L, PLUCKTHUN A: Selecting and evolving functional proteins in vitro by ribosome display. Methods Enqmol. (2000) 328:404–430.
   PubMed Web of Science ®Google Scholar
• POOLE E, TATE W: Release factors and their role as decoding proteins: specificity and fidelity for termination of protein synthesis. Biochim. Biophys. Acta (2000) 1493(1-2):1–11.
   PubMed Web of Science ®Google Scholar
• VERMA R, BOLETI E, GEORGIE AJ: Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J. Immunol Methods (1998) 216(1-2):165–181.
   PubMed Web of Science ®Google Scholar
• SKERRA A, PLUCKTHUN A: Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science (1988) 240(4855):1038–1041.
   PubMed Web of Science ®Google Scholar
• BIRD RE, HARDMAN KD, JACOBSON jw et al.: Single-chain antigen binding proteins. Science (1988) 242:423–426.
   PubMed Web of Science ®Google Scholar
• MAKEYEV EV, KOLB VA, SPIRIN AS: Cell-free immunology: construction and in vitro expression of a PCR-based library encoding a single-chain antibody repertoire. FEBS Letts. (1999) 444(2-3):177–180.
   PubMed Web of Science ®Google Scholar
• JERMUTUS L, HONEGGER A, SCHWESINGER F, HANES J, PLUCKTHUN A: Tailoring in vitro evolution for protein affinity or stability. Proc. Nail Acad. Sci. USA (2001) 98(1):75–80.
   PubMed Web of Science ®Google Scholar
• •Demonstration of selection for stability improvements.
   Google Scholar
• HANES J, PLUCKTHUN A: In vitro selection and evolution of functional proteins by using ribosome display. Proc. Nail Acad. Sci. USA (1997) 94(10):4937–4942.
   PubMed Web of Science ®Google Scholar
• ••Definitive paper in terms of the definitionof conditions for the successful use of ribosome display using E. coli.
   Google Scholar
• HANES J, JERMUTUS L, WEBER-BORNHAUSER S, BOSSHARD HR, PLUCKTHUN A: Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc. Natl. Acad. Sci. USA (1998) 95(24):14130–14135.
   PubMed Web of Science ®Google Scholar
• HANES J, SCHAFFITZEL C, KNAPPIK A, PLUCKTHUN A: Picomolar affinity antibodies from a fully synthetic naïve library selected and evolved by ribosome display. Nat. Biotechnol. (2000) 18(12):1287–1292.
   PubMed Web of Science ®Google Scholar
• •Demonstration of selection from a naive library.
   Google Scholar
• SCHAFFITZEL C, BERGER I, POSTBERG J, LIPPS HJ, PLUCKTHUN A: In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc. NatL Acad. Sci. USA (2001) 98(15):8572–8577.
   PubMed Web of Science ®Google Scholar
• YAU KY, GROVES MA, LI Set al.: Selection of hapten-specific single domain antibodies from a non-immunised llama ribosome display library. J. Immunol. Methods (2003) 281(1–2):161–175.
   Google Scholar
• MATTHEAKIS LC, BHATT RR, DOWER WJ: An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc. NatL Acad. Sci. USA (1994) 91(19):9022–9026.
   PubMed Web of Science ®Google Scholar
• RYABOVA LA, DESPLANCQ D, SPIRIN AS, PLUCKTHUN A: Functional antibody production using cell-free translation; effects of protein disulphide isomerase and chaperones. Nat. Biotechnol. (1997) 15(1):79–84.
   PubMed Web of Science ®Google Scholar
• HE M, TAUSSIG MJ: Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res. (1997) 25(205132–5134.
   Google Scholar
• HEM, MENGES M, GROVES MA et al.: Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM display. J. Immunol. Methods (1999) 231(1-2):105–117.
   PubMed Web of Science ®Google Scholar
• •Demonstration of the use of a eukaryotic translation system and selection from a mouse library.
   Google Scholar
• KNAPPIK A, GEL, HONEGGER A et ed.: Fully synthetic human combinatorial antibody libraries (HUCAL) based on modular consensus frameworks and CDRs randomised with trinucleotides. J. MoL Biol. (2000) 296(1):57–86.
   Google Scholar
• GROVES MA, LANE S, DOUTHWAITE J, EDWARDS B: Affinity maturation of phage display antibody populations using ribosome display (2005) (In Preparation).
   Google Scholar
• ZAHND C, SPINELLI S, LUGINBUHL B, AMSTUTZ P, CAMBILLAU C, PLUCKTHUN A: Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity. J. Biol. Chem. (2004) 279(18):18870–18877.
   PubMed Web of Science ®Google Scholar
• CHEN Y, WIESMANN C, FUH G et aL:Selection and analysis of an optimised anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J. MoL Biol. (1999) 293(4):865–861.
   PubMed Web of Science ®Google Scholar
• ELLMARK P, ESTEBAN O, FUREBRING C, MALMORG HAGER AC, OHLIN M: In vitro molecular evolution of antibody genes mimicking receptor revision. MoL Immunol. (2002) 39(5-6):349–356.
   PubMed Web of Science ®Google Scholar
• BAKER KP, EDWARDS BM, MAIN SH et al.: Generation and characterisation of LymphoStat-B, a human monoclonal antibody that antagonises the bioactivities of B lymphocyte stimulator. Arthritis Rheum. (2003) 48(11):3253–3265.
   PubMed Web of Science ®Google Scholar
• FERMER C, ANDERSSON I, NILSSON K, NILSSON O: Specificity rescue and affinity maturation of a low-affinity IgM antibody against pro-gastrin-releasing peptide using phage display and DNA shuffling. Tumour Biol. (2004) 25(1-2):7–13.
   PubMed Web of Science ®Google Scholar
• CASALI P, SCHETTINO EW: Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol. (1996) 210:167–179.
   PubMed Web of Science ®Google Scholar
• FOOTE J, WINTER G: Antibody framework residues affecting the conformation of the hypervariable loops. Mo/. Bid. (1992) 224(2):487–499.
   PubMed Web of Science ®Google Scholar
• ARKIN MR, WELLS JA: Probing the importance of second sphere residues in an esterolytic antibody by phage display. Mo/. Bid. (1998) 284(4):1083–1094.
   PubMed Web of Science ®Google Scholar
• BACA M, SCANLAN TS, STEPHENSON RC, WELLS JA: Phage display of a catalytic antibody to optimise affinity for transition-state analog binding. Proc. NatL Acad. Sci. USA (1997) 94(19):10063–10068.
   PubMed Web of Science ®Google Scholar
• CALDAS C, COELHO V, KALIL J, MORO AM, MARANHAO AQ, BRIGIDO MM: Humanisation of the anti-CD18 antibody 6.7: an unexpected effect of a frame-work residue in binding to antigen. MoL Immunol. (2003) 39(15):941–952.
   Google Scholar
• WILLUDA, J, HONEGGER A. WAIBEL R et al.: High thermal stability is essential for tumour targeting of antibody fragments: Engineering of a humanised anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain HT fragment. Cancer Res. (1999) 59:5758–5767.
   Google Scholar
• BODER ET, MIDELFORT KS, WITTRUP KD: Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. NatL Acad. Sci. USA (2000) 97(20):10701–10705.
   PubMed Web of Science ®Google Scholar
• WATZKA H, PFIZENMAIER K, MOOSMAYER D: Guided selection of antibody fragments specific for human interferon gamma receptor 1 from a human VH- and VL-gene repertoire. Immunotech. (1998) 3(4):279–291.
   PubMedGoogle Scholar
• OSBOURN JK, GROVES MA, VAUGHAN T: From rodent reagents to human therapeutics using antibody guided selection. In: Humanized Antibodies and Their Application. Wu H (Ed.), Methods (2005).
   Google Scholar
• HANES J, JERMUTUS L, PLUCKTHUN A: Selecting and evolving functional proteins in vitro by ribosome display. Methods Enqmol. (2000) 328:404–430.
   PubMed Web of Science ®Google Scholar
• BIEBERICH E, KAPITONOV D, TENCOMNAO T, YU RK: Protein-ribosome-mRNA display: Affinity isolation of enzyme-ribosome-mRNA complexes and cDNA cloning in a single-tube reaction. Anal. Biochem. (2000) 287:294–298.
   PubMed Web of Science ®Google Scholar
• LAIVILA T, ERDMANN VA: In vitro selection of other proteins than antibodies by means of ribosome display. (2001) FEBS Lett. 502: 35–40.
   Google Scholar
• TAKAHASHI F, EBIHARA T, MIE M et al.: Ribosome display for selection of active dihydrofolate reductase mutants using immobilised methotrexate on agarose beads. FEBS Lett. (2002) 514:106–110.
   PubMed Web of Science ®Google Scholar
• COIA G, PONTES-BRAZ L, NUTTALL SD, HUDSON PJ, IRVING RA: Panning and selection of proteins using ribosome display. J. Immunol. Methods (2001) 254:191–197.
   PubMed Web of Science ®Google Scholar
• AMSTUTZ P, PELLETIER JN, GUGGISBERG A et al.: In vitro selection for catalytic activity with ribosome display. J. Am. Chem. Soc. (2002) 124(32)9396–9403.
   Google Scholar
• THORSTEN L, ERDMANN VA: Searching sequence space for high affinity binding peptides using ribosome display. MoL BioL (2003) 329:381–388.
   Web of Science ®Google Scholar
• MATSUURA T, PLUCKTHUN A: Strategies for selection from protein libraries composed of de novo designed secondary structure modules. Orig. Life Eva Biosph. (2004) 34(1-2):151–157.
   PubMed Web of Science ®Google Scholar
• HEM, TAUSSIG MJ: Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res. (2001) 29(15):E73.
   PubMedGoogle Scholar
• DOWER WJ, MATTHEAKIS LC: In vitro selection as a powerful tool for the applied evolution of proteins and peptides. Curr. Opin. Chem. Biol. (2002) 6(3):390–398.
   PubMed Web of Science ®Google Scholar
• HEM, TAUSSIG MJ: Ribosome display: cell-free protein display technology. Brief Funct. Genomic Proteomic. (2002) 1(2):204–212.
   PubMedGoogle Scholar
• HE M, TAUSSIG MJ: DiscernArray technology: a cell-free method for the generation of protein arrays from PCR DNA. J. Immunol Methods (2003) a274(1–2):265–270.
   Google Scholar
• WEICHHART T, HORKY M, SOLLNRE J et al: Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect. Immun. (2003) 71(8):4633–4641.
   PubMed Web of Science ®Google Scholar
• •Interesting application of ribosome display to the field of vaccine development.
   Google Scholar
• ROBERTS RW, SZOSTAK JW: RNA-peptide fusions for the in vitro selection of proteins and peptides. Proc. Nail. Acad. Sci. USA (1997) 94:12297–12302.
   PubMed Web of Science ®Google Scholar
• KURZ M, KUANG G, LOHSE Pk An efficient synthetic strategy for the preparation of nucleic acid-encoded peptide and protein libraries for in vitro evolution protocols. Molecules (2000) 5:1259–1264.
   Web of Science ®Google Scholar
• KURZ M, KUANG G, LOHSE Pk Psoralen photo-crosslinked mRNA-puromycin conjugates: a novel template for the rapid and facile preparation of mRNA-protein fusions. Nucleic Acids Res. (2000) 28:E83.
   PubMedGoogle Scholar
• KEEFE AD, SZOSTAK JW: Functional proteins from a random-sequence library. Nature (2001) 410(6829):715–718.
   PubMed Web of Science ®Google Scholar
• CHAPUT JC, SZOSTAK JW: Evolutionary optimisation of a nonbiological ATP binding protein for improved folding stability. Chem. Biol. (2004) 11(61:865-874. Patent
   Google Scholar
• KAWASAKI GH: WO 91/05058 (1991). Affiliation Maria AT Groves 8c Jane K Osbourrtl lAuthor for correspondence Cambridge Antibody Technology, Milstein Building, Granta Park, Cambridge, CB1 6GH, UK
   Google Scholar